AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2022
Feb 14, 2022
30339_dirs_2022-02-14_745fc725-c13f-4341-bba0-7329017e3762.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2022-02-13
Reporting Person: MONTECALVO DAVID A (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-02-13 | Common Stock | F | 27.00 | $391.20 | Disposed | 10134.42 | Direct |
Footnotes
F1: Shares withheld to cover taxes related to Bonus and incentive shares granted on February 13, 2018.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27